Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011590
Filing Date
2025-08-14
Accepted
2025-08-14 17:00:54
Documents
74
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elut-20250630x10q.htm   iXBRL 10-Q 2218259
2 EX-31.1 elut-20250630xex31d1.htm EX-31.1 15025
3 EX-31.2 elut-20250630xex31d2.htm EX-31.2 14993
4 EX-32.1 elut-20250630xex32d1.htm EX-32.1 6670
5 EX-32.2 elut-20250630xex32d2.htm EX-32.2 6610
  Complete submission text file 0001558370-25-011590.txt   8737234

Data Files

Seq Description Document Type Size
6 EX-101.SCH elut-20250630.xsd EX-101.SCH 60249
7 EX-101.CAL elut-20250630_cal.xml EX-101.CAL 50336
8 EX-101.DEF elut-20250630_def.xml EX-101.DEF 307100
9 EX-101.LAB elut-20250630_lab.xml EX-101.LAB 541883
10 EX-101.PRE elut-20250630_pre.xml EX-101.PRE 436294
77 EXTRACTED XBRL INSTANCE DOCUMENT elut-20250630x10q_htm.xml XML 1408528
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
ELUTIA INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 251220681
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)